Can Europe become a major player in cell and gene therapy?
Drug Discovery World
NOVEMBER 24, 2022
A new report by Charles River Associates for the European Federation of Pharmaceutical Industries and Associations (EFPIA has revealed that Europe is falling behind the US and Asia in its pharmaceutical R&D investment, particularly when it comes to Advanced Therapies Medicinal Products (ATMPs) like tissue, gene and cell therapies. .
Let's personalize your content